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Community-acquired pneumonia (CAP) remains
a serious disease with significant mortality. The
mortality rate for all hospitalized CAP patients is
10–15%,1,2 and 20–50% of the mortality of those
who require admission to an intensive care unit
(ICU) is caused by CAP.3,4 Disease severity assess-
ment is important for guiding therapeutic options.5
An accurate assessment can help the physician to
determine the initial site of care and to select 
empirical therapy. Early identification of patients
with severe CAP and high risk of mortality will
help to ensure that empirical therapy is prompt
and directed at the most likely pathogens. It also
supports the physician’s decision making regard-
ing the need for ICU admission. The Pneumonia
Severity Index (PSI) is a good tool for predicting
pneumonia mortality. It is best validated for assess-
ing patients with a low mortality risk who may
be suitable for outpatient management.6–9 How-
ever, our previous study found a low specificity
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and positive predictive value (PPV) (58% and
18%, respectively) of PSI for mortality in patients
with severe CAP (PSI class IV and V patients).10
Our aim was to evaluate whether repeated mea-
surement of PSI at 72 hours after admission can
improve the value of this index in identifying CAP
patients at high risk of hospital mortality.
Methods
All patients with CAP treated from May 2005 to
February 2006 at National Cheng Kung University
Hospital, a tertiary referral medical center in south-
ern Taiwan, were included in this study. The study
was approved by the Institutional Review Board,
and all patients provided signed informed con-
sent. The prediction rule using the PSI scoring
system was evaluated using data obtained by a
prospective observational study method.
Disease definitions and complete inclusion
and exclusion criteria were as previously de-
scribed.7 To be included, patients had to have:
(1) symptoms and signs of respiratory tract in-
fection, such as cough, fever and sputum; (2)
acute pulmonary infiltrates present on chest ra-
diography that were compatible with pneumo-
nia; and (3) acquisition of infection outside the
confines of a hospital, chronic care facility, or
nursing home. Patients were excluded if they had
known human immunodeficiency virus infection
or had evidence of active tuberculosis Data on
demographic characteristics, comorbidity, base-
line clinical and laboratory features, and hospital
mortality were obtained during admission. We
evaluated the PSI score immediately after admis-
sion and repeated PSI measurements were stud-
ied about 72 hours after admission. For repeated
PSI score, the PSI parameters were evaluated
about 72 hours after admission in every patient
except those patients who died within 72 hours
of admission.
Our aim was to evaluate whether repeated
measurement of the PSI score at 72 hours after
admission improved its value in predicting which
patients had a high risk of mortality. The mortality
in stratified risk class of initial PSI was calculated.
The performances including sensitivity, specificity,
PPV, negative predictive value (NPV) and accuracy
of initial PSI and increased repeated PSI score for
predicting mortality in severe CAP (class IV and V)
were also calculated.
Results are expressed as mean ± standard devi-
ation. Categorical variables were compared using
the χ2 or Fisher’s exact test as appropriate. All tests
were interpreted using a two-tailed significance
level of p < 0.05.
Results
Two hundred and fifty patients were enrolled in
this prospective study. The demographic charac-
teristics, comorbidity, physical examination find-
ings and laboratory data for these patients are
shown in Table 1.
The correlation of inhospital mortality with
PSI risk classification at admission is shown in
Table 2. For the initial PSI score, the total class-
specific mortality ranged from 2.9% for class III,
to 7.8% for class IV, and 25.3% for class V 
(p < 0.001). No mortality occurred among pa-
tients in class I and II.
To test whether repeated measurement of the
PSI score could more accurately predict mortal-
ity, PSI was reassessed 72 hours after admission
in all patients, except the seven patients who
died within the first 72 hours of admission (one
with PSI class III and six with class V). The re-
peated PSI score was compared with the initial
PSI score for each patient (Table 3). Patients
whose repeated PSI score decreased compared
with the initial value had a lower mortality rate
(from 7.8% to 3.7% in class IV patients, and
25.3% to 13% in class V), while those with an
increased repeated PSI score had an increased
mortality rate (from 7.8% to 33.3% in class IV
patients, and 25.3% to 53.3% in class V). The
specificity and PPV of an increased repeated PSI
score for predicting hospital mortality in high-
risk patients increased from 37% to 94% and
from 17% to 46%, respectively, and the accuracy
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also increased from 44% to 90%, as compared
with initial PSI scores (Table 4). Increased PSI
score 72 hours after admission predicted the out-
come of severe CAP better than the initial PSI
score did.
Discussion
The PSI is designed to identify patients with CAP
who are at a low risk of mortality and other ad-
verse outcomes. This information can help physi-
cians to make more rational decisions about the
site of care for patients with CAP. A previous
study has found that the admission rate decreased
after implementation of admission decisions in
combination with specific recommendations for
outpatient antibiotic therapy.11 Disease severity
assessment is also important for the early identi-
fication of high-risk patients who not only require
admission, but who also require ICU manage-
ment. An accurate assessment also helps the 
physician to make decisions about the extent of
diagnostic testing, and the type and intensity of
antibiotic treatment.12
The PSI is best validated for assessing patients
with a low mortality risk who may be suitable for
treatment as outpatients, rather than in predict-
ing inhospital mortality for those with severe
CAP.6–9 We also demonstrated a significant cor-
relation between PSI class and inhospital mortal-
ity. Although this finding confirms that PSI is a
powerful tool for identifying low-risk patients,
the specificity and PPV for predicting mortality
in high-risk patients (class IV and class V) were
low (37% and 17%, respectively). These results
are similar to those of our previous study10 and
another study13 that used PSI to predict mortality
of high-risk patients with CAP, and also found a
low specificity of 58–70% and low PPV of 11–18%.
Halm et al found that the median time to over-
all clinical stability in hospitalized patients with
Repeated PSI and severity of CAP
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Table 1. Demographic characteristics of the
patients (n = 250)
n (%)
Demographic characteristics
Age < 50 yr 44 (18)
Female 89 (36)
Comorbidities
Diabetes mellitus 58 (23)
Chronic lung disease 55 (22)
Cerebrovascular 53 (21)
Chronic renal disease 38 (15)
Chronic liver disease 30 (12)
Chronic heart failure 28 (11)
Neoplasm 24 (10)
Alcohol abuse 12 (5)
Smoking 53 (21)
Physical examination
Altered mental status 61 (24)
Pulse ≥ 125 beats/min 67 (27)
Respiratory rate ≥ 30 beats/min 78 (31)
Systolic blood pressure < 90 mmHg 39 (16)
Temperature < 35°C or ≥ 40°C 23 (9)
Laboratory
Urea ≥ 30 mg/dL 65 (26)
Glucose ≥ 250 mg/dL 26 (10)
Hematocrit < 30% 40 (16)
Sodium < 130 mmol/L 34 (14)
PaO2 < 60 mmHg 131 (52)
Arterial pH < 7.35 36 (14)
Table 2. Initial PSI score and risk class specific mortality for patients with CAP
PSI class at admission Total number (%) Mortality number (%)*
I 21 (8.4) 0
II 26 (10.4) 0
III 35 (14.0) 1 (2.9)
IV 77 (30.8) 6 (7.8)
V 91 (36.4) 23 (25.3)
Total 250 (100) 30 (12.0)
*Mortality was significantly associated with risk class (p < 0.001).
CAP was 3 days.14 Most patients with CAP have
an adequate clinical response within 3 days. How-
ever, up to 10% of all CAP patients do not re-
spond to initial therapy.5 Therefore, it is reasonable
to hypothesize that repeated measurement of PSI
score 72 hours after admission might improve the
utility of this instrument. The change in serial PSI
score from initial measurement to repeated evalu-
ation at 72 hours after admission revealed that
the mortality rate decreased if the repeated PSI
score decreased, and increased if the repeated PSI
score increased in high-risk patients (class IV and
class V). Thus, this comparison of initial and re-
peated PSI scores allowed more accurate predic-
tion of hospital mortality because of improved
specificity and PPV (94% and 46%, respectively).
This repeated assessment may thus help physi-
cians detect the most severe CAP patients, who
have significantly higher mortality rates (33.3%
in class IV and 53.3% in class V). Focusing on the
identification of high-risk patients through re-
peated PSI assessment may assist in their rapid
triage and aggressive management, and reduce
subsequent mortality from severe CAP. However,
the relatively low sensitivity of the performance
of the increased repeated PSI score, also reminded
us that, even though the mortality was decreased,
there were still some patients with stationary or
decreased repeated PSI score who will die.
In conclusion, we demonstrated that the PSI
scoring system had low specificity and low PPV
for mortality in high-risk patients with CAP.
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Table 3. Compared repeated PSI score with initial PSI score for predicting mortality of patients with CAP
Initial PSI class and
Change of score by 
Median (range) for Mortality
predicted mortality
comparing repeated Case number
change of score number (%)
PSI with initial PSI
Class I (0%) Decreased 0 0
Stationary 21 0
Increased 0 0
Class II (0%) Decreased 8 −12.5 (10–30) 0
Stationary 17 0
Increased 1 10 0
Class III (2.9%) Decreased 12 −17.5 (10–45) 0
Stationary 20 0
Increased 2 40 (10–70) 0
Class IV (7.8%) Decreased 54 −25 (10–50) 2 (3.7)
Stationary 14 1 (7.1)
Increased 9 30 (10–90) 3 (33.3)*
Class V (25.3%) Decreased 69 −40 (10–100) 9 (13.0)
Stationary 1 0
Increased 15 30 (10–70) 8 (53.3)†
*p<0.02 and †p<0.01 as compared with the pool data of stationary and decreased patients in the same class. We defined three categories:
“decreased”, “stationary” and “increased” for change of repeated PSI score. “Stationary” means exactly the same score, “decreased” means
any decreased scores and “increased” means any increased score as compared with the initial PSI score.
Table 4. Comparison of the performance characteristics of initial PSI ≥ Class IV and increased repeated PSI
score in Class IV and V patients for predicting the mortality of CAP
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Initial PSI 97 37 17 99 44
Increased repeated PSI score 48 94 46 95 90
Repeated assessment with increased PSI score 
72 hours after admission improved the per-
formance of the PSI scoring system for identi-
fying patients at high risk of mortality.
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